JP2020512401A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512401A5
JP2020512401A5 JP2020501438A JP2020501438A JP2020512401A5 JP 2020512401 A5 JP2020512401 A5 JP 2020512401A5 JP 2020501438 A JP2020501438 A JP 2020501438A JP 2020501438 A JP2020501438 A JP 2020501438A JP 2020512401 A5 JP2020512401 A5 JP 2020512401A5
Authority
JP
Japan
Prior art keywords
cyano
piperidine
phenyl
difluorophenoxy
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020501438A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020512401A (ja
JP7142675B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/024249 external-priority patent/WO2018183145A1/en
Publication of JP2020512401A publication Critical patent/JP2020512401A/ja
Publication of JP2020512401A5 publication Critical patent/JP2020512401A5/ja
Application granted granted Critical
Publication of JP7142675B2 publication Critical patent/JP7142675B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020501438A 2017-03-26 2018-03-26 Gpr6のモジュレーターとしてのピペリジニルおよびピペラジニル置換された複素芳香族カルボキサミド Active JP7142675B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762476786P 2017-03-26 2017-03-26
US201762476846P 2017-03-26 2017-03-26
US62/476,846 2017-03-26
US62/476,786 2017-03-26
PCT/US2018/024249 WO2018183145A1 (en) 2017-03-26 2018-03-26 Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of gpr6

Publications (3)

Publication Number Publication Date
JP2020512401A JP2020512401A (ja) 2020-04-23
JP2020512401A5 true JP2020512401A5 (enExample) 2021-05-06
JP7142675B2 JP7142675B2 (ja) 2022-09-27

Family

ID=63676658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020501438A Active JP7142675B2 (ja) 2017-03-26 2018-03-26 Gpr6のモジュレーターとしてのピペリジニルおよびピペラジニル置換された複素芳香族カルボキサミド

Country Status (11)

Country Link
US (1) US11426397B2 (enExample)
EP (1) EP3600312B1 (enExample)
JP (1) JP7142675B2 (enExample)
CN (1) CN110520127B (enExample)
AU (1) AU2018244211B2 (enExample)
CA (1) CA3054945A1 (enExample)
DK (1) DK3600312T3 (enExample)
FI (1) FI3600312T3 (enExample)
IL (1) IL269189B2 (enExample)
MX (1) MX390512B (enExample)
WO (1) WO2018183145A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020099603A1 (en) * 2018-11-14 2020-05-22 Allinky Biopharma Pyridin-sulfonamide compounds for the treatment of conditions related to interleukin 1 beta
CA3162166A1 (en) 2019-12-02 2021-06-10 Storm Therapeutics Limited Polyheterocyclic compounds as mettl3 inhibitors
CN116261453A (zh) 2020-08-13 2023-06-13 勃林格殷格翰国际有限公司 与思觉失调症相关的认知障碍的治疗
CA3195702A1 (en) 2020-10-13 2022-04-21 Boehringer Ingelheim International Gmbh Process of reworking
WO2022240992A1 (en) * 2021-05-12 2022-11-17 Libra Therapeutics, Inc. Heterocyclic trpml1 agonists and uses thereof
CN120917015A (zh) * 2023-01-20 2025-11-07 元启(苏州)生物制药有限公司 Srpk1抑制剂和使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
ES2332505T3 (es) 2001-06-01 2010-02-08 F. Hoffmann-La Roche Ag Derivados de pirimidina, triazina y pirazina como receptores de glutamato.
JP2005516903A (ja) * 2001-11-30 2005-06-09 エフ.ホフマン−ラ ロシュ アーゲー 喘息の処置におけるccr−3受容体拮抗物質として使用するためのピペラジン誘導体
US20040034019A1 (en) 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives
US8163746B2 (en) * 2006-04-19 2012-04-24 Astellas Pharma Inc. Azolecarboxamide derivative
MX2009004786A (es) * 2006-10-31 2009-06-05 Schering Corp Derivados de anilinopiperazina y sus metodos de uso.
PE20091576A1 (es) 2008-02-19 2009-11-05 Sanofi Aventis DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3
US9487526B2 (en) * 2012-08-13 2016-11-08 Takeda Pharmaceutical Company Limited Quinoxaline derivatives as GPR6 modulators
US10000468B2 (en) * 2014-02-14 2018-06-19 Takeda Pharmaceutical Company Limited Pyrazines as modulators of GPR6
GB201406956D0 (en) * 2014-04-17 2014-06-04 Univ Nottingham Compounds

Similar Documents

Publication Publication Date Title
JP2020512401A5 (enExample)
HRP20251479T1 (hr) Pesticidno aktivni kondenzirani biciklički heteroaromatski spojevi
FI3600312T3 (fi) Piperidinyyli- ja piperatsinyylisubstituoituja heteroaromaattisia karboksamideja gpr6:n modulaattoreina
RU2417994C2 (ru) Производные пиразина, полезные в качестве антагонистов аденозинового рецептора
RU2008141761A (ru) ИНГИБИТОРЫ с-МЕТ ПРОТЕИНКИНАЗЫ
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2013528591A5 (enExample)
JP2016523911A5 (enExample)
JP2007510689A5 (enExample)
JP2013515032A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
JP2011503166A5 (enExample)
JP2010513444A5 (enExample)
RU2018123779A (ru) Новые соединения
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
JP2019504009A5 (enExample)
JP2012510989A5 (enExample)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2010514677A5 (enExample)
RU2017125520A (ru) Соединения, ингибирующие parg
JP2010513304A5 (enExample)
JP2016500073A5 (enExample)
JP2009525978A5 (enExample)
JP2009519967A5 (enExample)